@prefix bibo: <http://purl.org/ontology/bibo/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

<https://doi.org/10.1007/s12672-025-03561-5> a bibo:AcademicArticle ;
    rdfs:label "Immunotherapeutics in metastatic cancer management" ;
    mesh:hasSubject "CAR-T cells",
        "Cancer vaccines",
        "Immune checkpoint inhibitors",
        "Immunotherapy",
        "Metastatic cancer",
        "Tumor microenvironment" ;
    dcterms:identifier "12618787" ;
    dcterms:issued "2025-11-14" ;
    dcterms:subject "CAR-T cells",
        "Cancer vaccines",
        "Immune checkpoint inhibitors",
        "Immunotherapy",
        "Metastatic cancer",
        "Tumor microenvironment" ;
    dcterms:title "Immunotherapeutics in metastatic cancer management" ;
    bibo:doi "10.1007/s12672-025-03561-5" ;
    bibo:issue "1" ;
    bibo:journal "Discover Oncology" ;
    bibo:pages "17-48" ;
    bibo:volume "16" ;
    owl:sameAs <https://doi.org/10.1007/s12672-025-03561-5>,
        <https://www.ncbi.nlm.nih.gov/pmc/articles/12618787/> ;
    prov:generatedAtTime "2025-11-24T11:19:00.616046" ;
    prov:wasDerivedFrom <urn:pmc:12618787> ;
    prov:wasGeneratedBy "pyeuropepmc_parser" .

<https://doi.org/10.1016/j.mtbio.2025.102530> a bibo:AcademicArticle ;
    rdfs:label "Overcoming barriers in primary bone cancer: Nanomaterial-enabled immunotherapy" ;
    mesh:hasSubject "Combination therapy",
        "Immunotherapy",
        "Multifunctional nanoparticles",
        "Nanomaterial",
        "Primary bone neoplasms" ;
    dcterms:identifier "12639873" ;
    dcterms:issued "2025-11-07" ;
    dcterms:subject "Combination therapy",
        "Immunotherapy",
        "Multifunctional nanoparticles",
        "Nanomaterial",
        "Primary bone neoplasms" ;
    dcterms:title "Overcoming barriers in primary bone cancer: Nanomaterial-enabled immunotherapy" ;
    bibo:doi "10.1016/j.mtbio.2025.102530" ;
    bibo:issue "1" ;
    bibo:journal "Materials Today Bio" ;
    bibo:pages "2037-2043" ;
    bibo:volume "35" ;
    owl:sameAs <https://doi.org/10.1016/j.mtbio.2025.102530>,
        <https://www.ncbi.nlm.nih.gov/pmc/articles/12639873/> ;
    prov:generatedAtTime "2025-11-24T11:19:00.675798" ;
    prov:wasDerivedFrom <urn:pmc:12639873> ;
    prov:wasGeneratedBy "pyeuropepmc_parser" .

<https://doi.org/10.21037/tcr-2025-996> a bibo:AcademicArticle ;
    rdfs:label "Identification of cancer-associated fibroblast subpopulation and construction of an immunotherapy signature for gastric cancer" ;
    mesh:hasSubject "Heterogeneous subpopulation",
        "immunotherapy response",
        "prognosis",
        "tumor microenvironment" ;
    dcterms:identifier "12605440" ;
    dcterms:issued "2025-10-31" ;
    dcterms:subject "Heterogeneous subpopulation",
        "immunotherapy response",
        "prognosis",
        "tumor microenvironment" ;
    dcterms:title "Identification of cancer-associated fibroblast subpopulation and construction of an immunotherapy signature for gastric cancer" ;
    bibo:doi "10.21037/tcr-2025-996" ;
    bibo:issue "10" ;
    bibo:journal "Translational Cancer Research" ;
    bibo:pages "6316-6329" ;
    bibo:volume "14" ;
    owl:sameAs <https://doi.org/10.21037/tcr-2025-996>,
        <https://www.ncbi.nlm.nih.gov/pmc/articles/12605440/> ;
    prov:generatedAtTime "2025-11-24T11:19:00.621257" ;
    prov:wasDerivedFrom <urn:pmc:12605440> ;
    prov:wasGeneratedBy "pyeuropepmc_parser" .

<https://doi.org/10.2147/CMAR.S548762> a bibo:AcademicArticle ;
    rdfs:label "A Rare Case of Chemotherapy Combined with Immunotherapy for Dual Primary AFP-Positive Gastric Cancer and Synchronous Small Cell Lung Cancer" ;
    mesh:hasSubject "AFPGC",
        "SCLC",
        "case report",
        "immunotherapy",
        "tislelizumab" ;
    dcterms:identifier "12628704" ;
    dcterms:issued "2025-11-15" ;
    dcterms:subject "AFPGC",
        "SCLC",
        "case report",
        "immunotherapy",
        "tislelizumab" ;
    dcterms:title "A Rare Case of Chemotherapy Combined with Immunotherapy for Dual Primary AFP-Positive Gastric Cancer and Synchronous Small Cell Lung Cancer" ;
    bibo:doi "10.2147/CMAR.S548762" ;
    bibo:issue "11" ;
    bibo:journal "Cancer Management and Research" ;
    bibo:pages "2785-2791" ;
    bibo:volume "17" ;
    owl:sameAs <https://doi.org/10.2147/CMAR.S548762>,
        <https://www.ncbi.nlm.nih.gov/pmc/articles/12628704/> ;
    prov:generatedAtTime "2025-11-24T11:19:00.623900" ;
    prov:wasDerivedFrom <urn:pmc:12628704> ;
    prov:wasGeneratedBy "pyeuropepmc_parser" .

<https://doi.org/10.36401/JIPO-25-15> a bibo:AcademicArticle ;
    rdfs:label "Characterizing Inquiries About Novel Cancer Therapies: Findings from the National Cancer Institute’s Cancer Information Service" ;
    mesh:hasSubject "health communication",
        "immunotherapy",
        "patient education",
        "stem cell transplantation",
        "targeted therapy" ;
    dcterms:identifier "12550823" ;
    dcterms:issued "2025-10-20" ;
    dcterms:subject "health communication",
        "immunotherapy",
        "patient education",
        "stem cell transplantation",
        "targeted therapy" ;
    dcterms:title "Characterizing Inquiries About Novel Cancer Therapies: Findings from the National Cancer Institute’s Cancer Information Service" ;
    bibo:doi "10.36401/JIPO-25-15" ;
    bibo:issue "4" ;
    bibo:journal "Journal of Immunotherapy and Precision Oncology" ;
    bibo:pages "249-253" ;
    bibo:volume "8" ;
    owl:sameAs <https://doi.org/10.36401/JIPO-25-15>,
        <https://www.ncbi.nlm.nih.gov/pmc/articles/12550823/> ;
    prov:generatedAtTime "2025-11-24T11:19:00.607725" ;
    prov:wasDerivedFrom <urn:pmc:12550823> ;
    prov:wasGeneratedBy "pyeuropepmc_parser" .
